lancemunn

Bioengineer, Tumor Biologist

[Mass General Brigham Research @MGBResearchNews]

In a new @PNASNews publication, @MGHSteeleLabs @MassGeneralMDs @MGHCancerCenter researchers and colleagues created a mathematical model to predict the long-term effectiveness of COVID-19 vaccine booster doses in different patient populations.

Read more: https://t.co/JnXBxEbzfG

[Edwin L. Steele Laboratories @MGHSteeleLabs]

Collaboration between the Steele Labs and City College of New York shows that renal cancer uses mechanotransduction mechanisms to metastasize.
https://t.co/2eWX6l81dN

[lancemunn @lancemunn]

Our new COVID-19 modeling paper just came out in EBioMedicine. Congratulations to our dedicated team!
https://t.co/d2E8CSxjAV

[Ashish Verma, MD @AshuNephro]

Comparing machine learning algorithms for predicting ICU admission and mortality in COVID-19. @sonusubudhi @ankitbpatel7 @CoreyHardin2 @lancemunn @Nature_NPJ @TriantafyllosS4 @BrighamResearch @MGH_RI @MGHSteeleLabs https://t.co/MvpnXmZN8R

[PNASNews @PNASNews]

The outcome of SARS-CoV-2 treatments could largely depend on the response rate of cytotoxic T cells, suggesting optimal treatments will likely involve therapies that enhance T cell response. In PNAS: https://t.co/m0Eeiu8zYl #COVID19

[lancemunn @lancemunn]

Our review is finally out today! See why physical scientists are needed for cancer research:
https://t.co/ic8fRBm8Lc
@NCIPhySci @ASIPath @MGHSteeleLabs @MGH_RI
#Science #Cancer